Chapter outlines
DIABETIC KETOACIDOSIS |
Definition |
Pathophysiology |
Treatment |
Fluid replacement |
- Basic principles |
- Rate of fluid replacement |
- Selecting right fluid for replacement |
Insulin therapy |
Potassium supplementation |
Treatment of metabolic acidosis |
Correction of hypophosphatemia |
Identify and Treat Precipitating Factors |
Avoidance of Therapy Related Complications |
Monitoring of Treatment |
HYPEROSMOLAR HYPERGLYCEMIC STATE |
Presentation |
Diagnosis |
Treatment |
Fluid therapy |
Insulin treatment |
Electrolyte management |
Supportive treatment |
Monitoring |
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are serious and potentially life-threatening metabolic complications of diabetes mellitus (DM). While DKA is a common hyperglycemic emergency with a low mortality rate, characterized by hyperglycemia and ketoacidosis, HHS, on the other hand, is less common, characterized by hyperglycemia and hyperosmolality without ketoacidosis, but has a high mortality rate.
DIABETIC KETOACIDOSIS
Diabetic ketoacidosis is a medical emergency that can be life-threatening if not treated promptly. DKA is one of the common complications of type-I diabetes mellitus (IDDM) associated with significant fluid and electrolyte imbalance.
DEFINITION
Diabetic ketoacidosis is characterized by the triad of [1, 2]:
- Hyperglycemia: Blood glucose concentration of >200 mg/dL or 11.0 mmol/L.
- Metabolic acidosis: Venous pH <7.3 and serum bicarbonate <18 mmol/L [1] (or 15 mmol/L [2]).
- Ketonemia or ketonuria: Capillary ketones >3 mmol/L or urine ketones ++ (“moderate or large”).
If a facility to measure blood beta-hydroxybutyrate (BOHB) concentration is available, it is a more precise and sensitive test to diagnose DKA [3].
REFERENCES
- Glaser N, Fritsch M, Priyambada L, et al: ISPAD Clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835–56.
- JBDS. JBDS-IP Joint British Diabetes Societies Inpatient Care Group. The Management of Diabetic Ketoacidosis in Adults, March 2023 Update: JBDS Guidelines [Internet]. London: ABCD; 2023 Mar. Available from: https://abcd.care/sites/abcd.care/files/site_uploads/JBDS_Guidelines_Current/JBDS_02_DKA_Guideline_with_QR_code_March_2023.pdf.
- Tremblay ES, Millington K, Monuteaux MC, et al. Plasma β-Hydroxybutyrate for the Diagnosis of Diabetic Ketoacidosis in the Emergency Department. Pediatr Emerg Care. 2021;37(12):e1345–e1350.
- Dhatariya K. Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. Rev Diabet Stud. 2016;13(4):217–225.
- Rawla P, Vellipuram AR, Bandaru SS, et al. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017;2017:17–0081.
- Nasa P, Chaudhary S, Shrivastava PK, et al. Euglycemic diabetic ketoacidosis: A missed diagnosis. World J Diabetes. 2021;12(5):514–523.
- Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343.
- Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(12):2739–48.
- English P, Williams G. Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J. 2004;80(943):253–261.
- DeFronzo RA, Hompesch M, Kasichayanula SK, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care 2013;36(10):3169–3176.
- Arora S, Cheng D, Wyler B, et al. Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med 2012;30(3):481–4.
- Adrogué HJ, Lederer ED, Suki WN, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986;65(3):163–172.
- Conte G, Dal Canton A, Imperatore P, et al. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int. 1990;38(2):301–7.
- Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome. Diabetes Spectrum 2002;15(1):28–36.
- Dhatariya KK, Nunney I, Higgins K, et al. A national survey of the management of diabetic ketoacidosis in the UK in 2014. Diabet Med. 2016;33(2):252–260.
- Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021;9(3):174–188.
- Mein SA, Schwartzstein RM, Richards JB. Sugar, Sodium, and Water: A Recipe for Disaster. Ann Am Thorac Soc. 2020;17(8):1016–1020.
- van der Vaart A, Waanders F, van Beek AP, et al. Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study. BMJ Open Diabetes Res Care. 2021;9(1):e002018.
- Choi HS, Kwon A, Chae HW, et al. Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia. Ann Pediatr Endocrinol Metab. 2018;23(2):103–106.
- Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. New England Journal of Medicine 2018;378(24):2275–2287.
- University Hospitals of Leicester. Management of Diabetic Ketoacidosis (DKA) in Adults Guideline (V4 approved by Policy and Guideline Committee on 27 February 2023 Trust ref: B66/2011) [Guidelines]. NHS; 2023. Available from: https://secure.library.leicestershospitals.nhs.uk/PAGL/Shared%20Documents/Diabetic%20Ketoacidosis%20(DKA)%20in%20Adults%20UHL%20Guideline.pdf.
- Fluid and insulin therapy in children and young people with diabetic ketoacidosis: An update to the NICE NG18 guideline. Journal of Diabetes Nursing 2021;25:JDN171. Available from: https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#fluid-and-insulin-therapy.
- Diabetes (type 1 and type 2) in children and young people: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2022 Jun 29. (NICE Guideline, No. 18.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK555102/.
- South Australia (SA) Health. Clinical practice guideline on diabetic ketoacidosis (DKA) in children. Adelaide: SA Health; 2019. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/04ac0b8040d0430e975ebf40b897efc8/Diabetic+Ketoacidosis+%28DKA%29+in+Children+and+Adolescents_Paed_v2_1.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-04ac0b8040d0430e975ebf40b897efc8-obYYWor.
- Diabetes Canada Clinical Practice Guidelines Expert Committee; Goguen J, Gilbert J. Hyperglycemic Emergencies in Adults. Can J Diabetes. 2018;42(1):S109–S114.
- Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243–51.
- Oliver WD, Willis GC, Hines MC, et al. Comparison of PlasmaLyte A and sodium chloride 0.9% for fluid resuscitation of patients with diabetic ketoacidosis. Hosp Pharm 2018;53(5):326–330.
- Yung M, Letton G, Keeley S. Controlled trial of Hartmann’s solution versus 0.9% saline for diabetic ketoacidosis. J Paediatr Child Health. 2017;53(1):12–17.
- Mahler S, Conrad S, Wang H, et al. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med. 2011;29(6):670–674.
- Ramanan M, Attokaran A, Murray L. SCOPE-DKA Collaborators and Queensland Critical Care Research Network (QCCRN). Sodium chloride or PlasmaLyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial. Intensive Care Med. 2021;47(11):1248–1257.
- Self W, Evans C, Jenkins C, et al. Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis. JAMA Netw Open. 2020;3:(11):e2024596.
- Van Zyl D, Rheeder P, Delport E. Fluid management in diabetic-acidosis Ringer’s lactate versus normal saline: a randomized controlled trial. QJM. 2012;105(4):337–343.
- Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis – a systematic review. Ann Intensive Care 2011;1(1):23.
- Bergmann KR, Abuzzahab MJ, Nowak J, et al. Resuscitation with Ringer’s lactate compared with normal saline for pediatric diabetic ketoacidosis. Pediatr Emerg Care 2021;37(5):e236–e242.
- Jahangir A, Jahangir A, Siddiqui FS, et al. Normal Saline Versus Low Chloride Solutions in Treatment of Diabetic Ketoacidosis: A Systematic Review of Clinical Trials. Cureus. 2022;14(1):e21324.
- Catahay JA, Polintan ET, Casimiro M, et al. Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: A systematic review and meta-analysis. Heart Lung. 2022;54:74–79.
- Alghamdi NA, Major P, Chaudhuri D, et al. Saline Compared to Balanced Crystalloid in Patients With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Explor. 2022;4(1):e0613.
- Zardoost P, Khan Z, Wehrum HL, et al. Hypernatremia in Diabetic Ketoacidosis: A Rare Metabolic Derangement Requiring a Cautionary Approach in Fluid Resuscitation. Cureus 2023;15(3):e36689.
- Dressler DD. Normal Saline vs. Balanced Crystalloid for Diabetic Ketoacidosis. NEJM JOURNAL Watch. 2022 Jul 26. Visit: https://www.jwatch.org/na55108/2022/07/26/normal-saline-vs-balanced-crystalloid-diabetic.
- Aldhaeefi M, Aldardeer NF, Alkhani N, et al. Updates in the Management of Hyperglycemic Crisis. Front Clin Diabetes Healthc. 2022;2:820728.
- Effects of Balanced Crystalloids vs. Saline in Adults with Diabetic Ketoacidosis [Internet]. Anaesthesia News. 2021. Available from: https://anaesthesianews.wordpress.com/2021/12/12/effects-of-balanced-crystalloids-vs-saline-in-adults-with-diabetic-ketoacidosis/.
- Farkas J. Diabetic Ketoacidosis (DKA). emcrit.org. 2021. Available from: https://emcrit.org/ibcc/dka/.
- Gripp K, Trottier ED, Thakore S, et al. Current recommendations for management of paediatric diabetic ketoacidosis. Canadian Paediatric Society 2022.
- BSPED Guideline for the Management of Children and Young People under the age of 18 years with Diabetic Ketoacidosis - 2021 [Internet]. British Society for Paediatric Endocrinology and Diabetes; 2021. Available from: https://www.bsped.org.uk/clinical-resources/bsped-dka-guidelines/.
- Forestell B, Battaglia F, Sharif S, et al. Insulin Infusion Dosing in Pediatric Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Explor. 2023;5(2):e0857.
- Kilpatrick ES, Butler AE, Ostlundh L, et al. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care. 2022;45(2):267–272.
- Ma OJ, Rush MD, Godfrey MM, et al. Arterial blood gas results rarely influence emergency physician management of patients with suspected diabetic ketoacidosis. Acad Emerg Med. 2003;10(8):836–41.
- Menchine M, Probst MA, Agy C, et al. Diagnostic accuracy of venous blood gas electrolytes for identifying diabetic ketoacidosis in the emergency department. Acad Emerg Med. 2011;18(10):1105–1108.
- Byrne AL, Bennett M, Chatterji R, et al. Peripheral venous and arterial blood gas analysis in adults: are they comparable? A systematic review and meta-analysis. Respirology. 2014;19(2):168–175.
- Prasad H, Vempalli N, Agrawal N, et al. Correlation and agreement between arterial and venous blood gas analysis in patients with hypotension-an emergency department-based cross-sectional study. Int J Emerg Med. 2023;16(1):18.
- Milanesi A, Weinreb JE. Hyperglycemic Hyperosmolar State. [Updated 2018 Aug 1]. In: Feingold KR, Anawalt B, Blackman MR, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278976/.
- Mustafa OG, Haq M, Dashora U, et al. Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabet Med. 2023;40(3):e15005.
- Zeitler P, Haqq A, Rosenbloom A, et al. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. Rev J Pediatr. 2011;158(1):9–14.